Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide. [electronic resource]
Producer: 19920709Description: 3116-29 p. digitalISSN:- 0006-4971
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antigens, CD -- immunology
- Antigens, CD19
- Antigens, Differentiation, B-Lymphocyte -- immunology
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Base Sequence
- Chromosome Aberrations
- Cyclophosphamide -- administration & dosage
- DNA, Neoplasm -- chemistry
- Humans
- Immunoglobulin mu-Chains -- analysis
- Immunophenotyping
- Immunotoxins -- therapeutic use
- Mice
- Mice, SCID
- Molecular Sequence Data
- N-Glycosyl Hydrolases
- Neoplasm Transplantation
- Plant Proteins -- administration & dosage
- Polymerase Chain Reaction
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Ribosome Inactivating Proteins, Type 1
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.